Sinusitis

Immunology·MeSH: Sinusitis

21 drugs in development·13 companies·2 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	SUNSET ISLAND GROUP (SUN)
Cefalexin Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
clarithromycin	SUNSET ISLAND GROUP (SUN)
Roxithromycin Dispersible Tablets	CHINA PHARMA HOLDINGS, INC. (CPHI)
xhance	Paratek Pharmaceuticals, Inc. (PRTK)

Phase 3(5)

Drug	Company
itepekimab	Sanofi (SNY)
Itepekimab	Sanofi (SNY)
lunsekimig	Sanofi (SNY)
LY3650150	ELI LILLY & Co (LLY)
Mometasone furoate nasal spray	Sanofi (SNY)

Phase 2(7)

Drug	Company
Antiretroviral Therapy	ELI LILLY & Co (LLY)
Itepekimab	REGENERON PHARMACEUTICALS, INC. (REGN)
lunsekimig	Sanofi (SNY)
Mometasone furoate nasal spray	INSMED Inc (INSM)
Oral versus topical antibioitics	UNITED THERAPEUTICS Corp (UTHR)
verekitug	Upstream Bio, Inc. (UPB)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

BLA Filed(1)

Drug	Company
xhance	OptiNose, Inc. (OPTN)

Phase 4(2)

Drug	Company
CM326 injection	Crinetics Pharmaceuticals, Inc. (CRNX)
omalizumab	Sanofi (SNY)

BioSniper tracks 21 drugs in development for Sinusitis across 13 companies.

There are 2 clinical trials targeting Sinusitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.